Related Experiment Video

Updated: Jul 9, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management

Athanassios Aessopos1, Vasilios Berdoukas, Maria Tsironi

  • 1First Department of Medicine, University of Athens, Laiko Hospital, Goudi, Athens, Greece. aaisopos@cc.uoa.gr

European Journal of Haematology
|December 18, 2007
PubMed

Insights

Cardiac disease is the main cause of death in thalassaemia major. Early diagnosis, intensive cardiac care, and tailored iron chelation therapy improve patient outcomes.

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Background:

  • Cardiac disease is the leading cause of mortality in patients with thalassaemia major.
  • Iron overload due to frequent blood transfusions contributes significantly to cardiac complications.

Purpose of the Study:

  • To review the mechanisms of heart failure in thalassaemia major.
  • To outline diagnostic and management strategies for acute cardiac failure.
  • To emphasize the importance of aggressive iron chelation and cardiac monitoring.

Main Methods:

  • Review of existing literature on cardiac disease in thalassaemia major.
  • Discussion of diagnostic tools, including cardiac MRI for iron assessment.
  • Analysis of current management guidelines for iron chelation therapy.

Main Results:

  • Heart failure in thalassaemia major has specific mechanisms and clinical presentations.
  • Intensive medical-cardiac care and effective iron chelation can lead to favorable long-term outcomes.
  • Cardiac MRI is a valuable tool for assessing cardiac iron load.

Conclusions:

  • Timely diagnosis and management of cardiac complications are crucial for improving survival in thalassaemia major.
  • Personalized iron chelation strategies based on cardiac iron levels are essential for prevention.
  • Multidisciplinary care integrating cardiology and hematology is recommended.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...